SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-22-010273
Filing Date
2022-04-29
Accepted
2022-04-29 16:36:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A pbyi20220427_defa14a.htm DEFA14A 10309
2 notice01.jpg GRAPHIC 171664
3 notice02.jpg GRAPHIC 141814
  Complete submission text file 0001437749-22-010273.txt   443099
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35703 | Film No.: 22876335
SIC: 2834 Pharmaceutical Preparations